Guertin, J. (2018) “IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS”, Journal of Population Therapeutics and Clinical Pharmacology, 21(3). Available at: http://www.jptcp.com/index.php/jptcp/article/view/302 (Accessed: 17 September 2026).